Concepts (171)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pain Management | 14 | 2025 | 180 | 3.020 |
Why?
|
| Chronic Pain | 9 | 2025 | 185 | 2.270 |
Why?
|
| Spinal Cord Stimulation | 5 | 2025 | 19 | 1.790 |
Why?
|
| Pain, Postoperative | 5 | 2020 | 276 | 1.480 |
Why?
|
| Analgesics | 5 | 2021 | 127 | 1.440 |
Why?
|
| Kyphoplasty | 2 | 2022 | 7 | 1.370 |
Why?
|
| Fractures, Compression | 2 | 2022 | 22 | 1.350 |
Why?
|
| Education, Medical, Graduate | 5 | 2024 | 425 | 1.310 |
Why?
|
| Spinal Fractures | 2 | 2022 | 102 | 1.250 |
Why?
|
| Analgesia, Epidural | 3 | 2019 | 42 | 1.240 |
Why?
|
| Perioperative Care | 6 | 2022 | 188 | 1.020 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 338 | 0.900 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 333 | 0.900 |
Why?
|
| Pandemics | 3 | 2020 | 873 | 0.870 |
Why?
|
| Fellowships and Scholarships | 5 | 2024 | 145 | 0.820 |
Why?
|
| Equipment Failure | 2 | 2016 | 118 | 0.810 |
Why?
|
| Analgesics, Opioid | 6 | 2025 | 513 | 0.770 |
Why?
|
| Pain, Intractable | 2 | 2013 | 8 | 0.760 |
Why?
|
| Vertebroplasty | 1 | 2022 | 16 | 0.720 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2022 | 25 | 0.710 |
Why?
|
| Drug Delivery Systems | 1 | 2022 | 194 | 0.640 |
Why?
|
| Hematoma, Epidural, Spinal | 1 | 2019 | 3 | 0.600 |
Why?
|
| Osteoarthritis, Knee | 3 | 2025 | 71 | 0.600 |
Why?
|
| Pain | 6 | 2023 | 414 | 0.590 |
Why?
|
| Orthopedics | 1 | 2021 | 134 | 0.590 |
Why?
|
| Orthopedic Procedures | 1 | 2021 | 150 | 0.590 |
Why?
|
| Osteoporotic Fractures | 1 | 2020 | 53 | 0.590 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 40 | 0.590 |
Why?
|
| Foreign-Body Migration | 1 | 2019 | 32 | 0.580 |
Why?
|
| Catheters | 1 | 2019 | 96 | 0.560 |
Why?
|
| Embolization, Therapeutic | 3 | 2025 | 272 | 0.540 |
Why?
|
| Artifacts | 1 | 2019 | 243 | 0.530 |
Why?
|
| Elective Surgical Procedures | 1 | 2019 | 163 | 0.530 |
Why?
|
| Anesthesia | 2 | 2022 | 175 | 0.520 |
Why?
|
| Failed Back Surgery Syndrome | 1 | 2016 | 2 | 0.490 |
Why?
|
| Internal-External Control | 1 | 2016 | 45 | 0.470 |
Why?
|
| Opioid-Related Disorders | 1 | 2019 | 233 | 0.460 |
Why?
|
| Prostheses and Implants | 1 | 2016 | 123 | 0.460 |
Why?
|
| Humans | 39 | 2025 | 93515 | 0.450 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2014 | 81 | 0.390 |
Why?
|
| Treatment Outcome | 11 | 2025 | 9099 | 0.370 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2012 | 6 | 0.370 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2025 | 3476 | 0.360 |
Why?
|
| Dexmedetomidine | 1 | 2012 | 17 | 0.360 |
Why?
|
| Pleura | 1 | 2012 | 30 | 0.360 |
Why?
|
| Mentors | 2 | 2025 | 98 | 0.350 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2012 | 51 | 0.350 |
Why?
|
| Depression | 1 | 2016 | 544 | 0.350 |
Why?
|
| Ketamine | 1 | 2011 | 26 | 0.350 |
Why?
|
| Catheters, Indwelling | 1 | 2012 | 101 | 0.340 |
Why?
|
| Pharmacogenetics | 4 | 2022 | 456 | 0.330 |
Why?
|
| Colectomy | 1 | 2012 | 192 | 0.330 |
Why?
|
| Ambulatory Care | 1 | 2011 | 193 | 0.310 |
Why?
|
| Pharmacogenomic Testing | 2 | 2021 | 107 | 0.300 |
Why?
|
| Spinal Cord | 3 | 2023 | 241 | 0.280 |
Why?
|
| Anesthesiology | 2 | 2022 | 167 | 0.280 |
Why?
|
| Telemedicine | 2 | 2021 | 225 | 0.270 |
Why?
|
| Betacoronavirus | 2 | 2020 | 283 | 0.260 |
Why?
|
| Prospective Studies | 5 | 2022 | 4560 | 0.230 |
Why?
|
| Cancer Pain | 1 | 2025 | 5 | 0.230 |
Why?
|
| Anesthetics, Local | 2 | 2018 | 83 | 0.230 |
Why?
|
| Back Pain | 1 | 2025 | 73 | 0.220 |
Why?
|
| United States | 4 | 2024 | 7622 | 0.220 |
Why?
|
| Mentoring | 1 | 2025 | 34 | 0.210 |
Why?
|
| Quality of Life | 3 | 2023 | 1780 | 0.200 |
Why?
|
| Career Choice | 1 | 2025 | 156 | 0.200 |
Why?
|
| Polyethylene Glycols | 1 | 2025 | 373 | 0.190 |
Why?
|
| Referral and Consultation | 1 | 2025 | 375 | 0.180 |
Why?
|
| Middle Aged | 8 | 2025 | 27573 | 0.180 |
Why?
|
| Electric Injuries | 1 | 2022 | 19 | 0.180 |
Why?
|
| Tramadol | 1 | 2022 | 14 | 0.180 |
Why?
|
| Injections, Spinal | 1 | 2022 | 48 | 0.180 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2021 | 10 | 0.180 |
Why?
|
| Medical Oncology | 1 | 2025 | 404 | 0.170 |
Why?
|
| Postoperative Period | 2 | 2019 | 315 | 0.170 |
Why?
|
| Drug Hypersensitivity | 1 | 2021 | 39 | 0.170 |
Why?
|
| Pharmacogenomic Variants | 1 | 2021 | 45 | 0.170 |
Why?
|
| Infusions, Intravenous | 2 | 2012 | 401 | 0.170 |
Why?
|
| Anesthetics | 1 | 2021 | 52 | 0.170 |
Why?
|
| Female | 13 | 2025 | 48702 | 0.170 |
Why?
|
| Radiology, Interventional | 1 | 2021 | 62 | 0.160 |
Why?
|
| Male | 12 | 2025 | 44557 | 0.160 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2023 | 283 | 0.160 |
Why?
|
| Brain Diseases | 1 | 2021 | 172 | 0.160 |
Why?
|
| Radiography, Interventional | 1 | 2021 | 148 | 0.160 |
Why?
|
| Workflow | 1 | 2020 | 77 | 0.160 |
Why?
|
| Extremities | 1 | 2021 | 176 | 0.150 |
Why?
|
| Job Satisfaction | 1 | 2020 | 80 | 0.150 |
Why?
|
| Surveys and Questionnaires | 4 | 2024 | 2802 | 0.150 |
Why?
|
| Decision Support Techniques | 1 | 2021 | 185 | 0.150 |
Why?
|
| Nociception | 1 | 2019 | 7 | 0.150 |
Why?
|
| Thoracotomy | 1 | 2019 | 68 | 0.140 |
Why?
|
| Health Personnel | 1 | 2020 | 234 | 0.140 |
Why?
|
| Femoral Nerve | 1 | 2018 | 9 | 0.140 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2020 | 624 | 0.140 |
Why?
|
| Median Arcuate Ligament Syndrome | 1 | 2018 | 23 | 0.140 |
Why?
|
| Decision Support Systems, Clinical | 1 | 2019 | 122 | 0.140 |
Why?
|
| Nerve Block | 1 | 2018 | 51 | 0.130 |
Why?
|
| Retrospective Studies | 4 | 2025 | 10164 | 0.130 |
Why?
|
| Vascular Surgical Procedures | 1 | 2018 | 150 | 0.130 |
Why?
|
| Contrast Media | 1 | 2021 | 988 | 0.120 |
Why?
|
| Bupivacaine | 2 | 2018 | 48 | 0.120 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2018 | 111 | 0.120 |
Why?
|
| Consensus | 3 | 2025 | 368 | 0.120 |
Why?
|
| Comorbidity | 2 | 2018 | 1007 | 0.120 |
Why?
|
| Critical Care | 1 | 2019 | 444 | 0.120 |
Why?
|
| Adolescent | 3 | 2020 | 9606 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 1914 | 0.110 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 1847 | 0.110 |
Why?
|
| Aged | 5 | 2025 | 20434 | 0.100 |
Why?
|
| Mental Disorders | 1 | 2018 | 455 | 0.100 |
Why?
|
| Capsaicin | 1 | 2013 | 43 | 0.100 |
Why?
|
| Administration, Topical | 1 | 2013 | 80 | 0.100 |
Why?
|
| Delphi Technique | 2 | 2025 | 135 | 0.100 |
Why?
|
| Infant | 1 | 2019 | 3220 | 0.090 |
Why?
|
| Arachnoiditis | 1 | 2012 | 2 | 0.090 |
Why?
|
| Clonidine | 1 | 2012 | 33 | 0.090 |
Why?
|
| Abdominal Abscess | 1 | 2012 | 23 | 0.090 |
Why?
|
| Anesthetics, Intravenous | 1 | 2012 | 43 | 0.090 |
Why?
|
| Young Adult | 3 | 2018 | 6930 | 0.090 |
Why?
|
| Dura Mater | 1 | 2012 | 45 | 0.090 |
Why?
|
| Neural Tube Defects | 1 | 2012 | 41 | 0.090 |
Why?
|
| Propofol | 1 | 2012 | 95 | 0.090 |
Why?
|
| Adult | 5 | 2025 | 27918 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 249 | 0.090 |
Why?
|
| Cicatrix | 1 | 2012 | 74 | 0.090 |
Why?
|
| Delirium | 1 | 2012 | 79 | 0.090 |
Why?
|
| Morphine | 1 | 2012 | 128 | 0.080 |
Why?
|
| Brain | 1 | 2021 | 2391 | 0.080 |
Why?
|
| Neoplasms | 1 | 2025 | 3169 | 0.080 |
Why?
|
| Breast Neoplasms | 1 | 2023 | 3110 | 0.070 |
Why?
|
| Evidence-Based Medicine | 2 | 2021 | 449 | 0.070 |
Why?
|
| Time Factors | 2 | 2018 | 5410 | 0.070 |
Why?
|
| Pain Measurement | 2 | 2018 | 373 | 0.060 |
Why?
|
| Prognosis | 2 | 2025 | 3911 | 0.060 |
Why?
|
| Risk Factors | 3 | 2021 | 5899 | 0.060 |
Why?
|
| Microspheres | 1 | 2025 | 88 | 0.060 |
Why?
|
| PubMed | 1 | 2024 | 16 | 0.050 |
Why?
|
| Ganglia, Spinal | 1 | 2024 | 72 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2021 | 2441 | 0.050 |
Why?
|
| Accreditation | 1 | 2024 | 73 | 0.050 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2023 | 99 | 0.050 |
Why?
|
| Arteries | 1 | 2023 | 171 | 0.050 |
Why?
|
| Omeprazole | 1 | 2022 | 11 | 0.050 |
Why?
|
| Succinylcholine | 1 | 2022 | 14 | 0.050 |
Why?
|
| Hydralazine | 1 | 2022 | 21 | 0.050 |
Why?
|
| Perfusion | 1 | 2023 | 260 | 0.040 |
Why?
|
| Oxycodone | 1 | 2022 | 35 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2021 | 291 | 0.040 |
Why?
|
| Executive Function | 1 | 2022 | 103 | 0.040 |
Why?
|
| Mastectomy | 1 | 2023 | 262 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2012 | 2562 | 0.040 |
Why?
|
| Combined Modality Therapy | 1 | 2024 | 1723 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2022 | 543 | 0.040 |
Why?
|
| Clinical Decision-Making | 1 | 2021 | 291 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2019 | 150 | 0.030 |
Why?
|
| Range of Motion, Articular | 1 | 2018 | 178 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2018 | 159 | 0.030 |
Why?
|
| Knee Joint | 1 | 2018 | 161 | 0.030 |
Why?
|
| Abdominal Pain | 1 | 2018 | 143 | 0.030 |
Why?
|
| Cognition | 1 | 2022 | 627 | 0.030 |
Why?
|
| Mental Health | 1 | 2018 | 188 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 1713 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2018 | 829 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2715 | 0.030 |
Why?
|
| Substance-Related Disorders | 1 | 2020 | 441 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 920 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2024 | 1090 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 828 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 660 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2018 | 1729 | 0.030 |
Why?
|